Publications
- Dimethyl fumarate in treating relapsing-remittin multiple sclerosis2015 | First Faculty of Medicine, Second Faculty of Medicine
- Dimethyl-fumarate in treating relapsing-remitting multiple sclerosis +12014 | Second Faculty of Medicine
- Cognitive impairment in early stages of multiple sclerosis2013 | First Faculty of Medicine, Second Faculty of Medicine
- Supportive strategies to improve adherence to IFN beta-1b in Multiple Sclerosis - Results of the BetaPlus observational cohort study2011 | Second Faculty of Medicine
- Repeated subcutaneous injections of IL12/23 P40 neutralising antibody, ustekinumab, in patients with relapsing-remitting multiple sclerosis: a phase II, double-blind, placebo-controlled, randomised, dose-ranging study2008 | Second Faculty of Medicine
- Is pregnancy in MS patients safe and what is its impact on MS course? Real World evidence of 1533 pregnancies in Czech Republic2022 | First Faculty of Medicine, Second Faculty of Medicine, Third Faculty of Medicine, Faculty of Medicine in Hradec Králové, Faculty of Medicine in Pilsen
- Prevalence of neurodegenerative/demyelinating disorders in patients with achalasia2022 | First Faculty of Medicine, Second Faculty of Medicine, Third Faculty of Medicine, Faculty of Physical Education and Sport
- Analysis of the Group of Pediatric Patients With Relapsing-Remitting Multiple Sclerosis: Data From the Czech National Registry2022 | Second Faculty of Medicine, Third Faculty of Medicine, Faculty of Medicine in Pilsen
- IL-2, IL-6 and chitinase 3-like 2 might predict early relapse activity in multiple sclerosis2022 | Second Faculty of Medicine
- Breastfeeding and multiple sclerosis2022 | Second Faculty of Medicine
Loading network view...